Portfolio (Quarterly)
Guide ↗
Arrowpoint Investment Partners (Singapore) Pte. Ltd.
· CIK 0002032331| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 81 | AXSM | AXSOME THERAPEUTICS INC | Healthcare | 2,110.0 | $385K | 0.06% | NEW | — | $182.64 | +27.9% |
| 82 | IMVT | IMMUNOVANT INC | Healthcare | 13,714.0 | $349K | 0.05% | NEW | — | $25.42 | +34.3% |
| 83 | VCSH | VANGUARD SCOTTSDALE FDS | — | 4,100.0 | $327K | 0.05% | NEW | — | $79.73 | -1.0% |
| 84 | NVST | ENVISTA HOLDINGS CORPORATION | Healthcare | 14,700.0 | $319K | 0.05% | NEW | — | $21.71 | +8.8% |
| 85 | TWST | TWIST BIOSCIENCE CORP | Healthcare | 9,992.0 | $317K | 0.05% | NEW | — | $31.72 | +69.2% |
| 86 | SOXX | ISHARES TR | — | 1,000.0 | $301K | 0.04% | NEW | — | $301.15 | +74.4% |
| 87 | CYTK | CYTOKINETICS INC | Healthcare | 4,480.0 | $285K | 0.04% | NEW | — | $63.54 | +22.9% |
| 88 | DYN | DYNE THERAPEUTICS INC | Healthcare | 14,383.0 | $281K | 0.04% | NEW | — | $19.56 | -11.2% |
| 89 | APLS | APELLIS PHARMACEUTICALS INC | Healthcare | 10,806.0 | $271K | 0.04% | NEW | — | $25.12 | +63.3% |
| 90 | ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | 10,011.0 | $267K | 0.04% | NEW | — | $26.71 | -20.2% |
| 91 | COGT | COGENT BIOSCIENCES INC | Healthcare | 7,353.0 | $261K | 0.04% | NEW | — | $35.52 | -8.3% |
| 92 | — | VENTYX BIOSCIENCES INC | — | 28,453.0 | $257K | 0.04% | NEW | — | $9.03 | — |
| 93 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 3,200.0 | $255K | 0.04% | NEW | — | $79.65 | +88.7% |
| 94 | TERN | TERNS PHARMACEUTICALS INC | Healthcare | 5,931.0 | $240K | 0.04% | NEW | — | $40.40 | +31.1% |
| 95 | MLYS | MINERALYS THERAPEUTICS INC | Healthcare | 6,384.0 | $232K | 0.03% | NEW | — | $36.29 | -16.7% |
| 96 | BBIO | BRIDGEBIO PHARMA INC | Healthcare | 2,925.0 | $224K | 0.03% | NEW | — | $76.49 | -8.1% |
| 97 | CRNX | CRINETICS PHARMACEUTICALS IN | Healthcare | 4,717.0 | $220K | 0.03% | NEW | — | $46.55 | -20.3% |
| 98 | MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | 371.0 | $216K | 0.03% | NEW | — | $582.34 | -11.8% |
| 99 | NKTR | NEKTAR THERAPEUTICS | Healthcare | 4,927.0 | $208K | 0.03% | NEW | — | $42.28 | +62.2% |
| 100 | ABVX | ABIVAX SA | Healthcare | 1,485.0 | $200K | 0.03% | NEW | — | $134.86 | -8.0% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
49.4%
Healthcare
20.2%
Consumer Cyclical
16.9%
Financial Services
12.7%
Communication Services
0.4%
Energy
0.2%
Industrials
0.2%